Biotechnology Stocks I Performance Guide: Genmab A/S (GMAB)
GMAB has no dividends
Table and Chart of GMAB Performance
See what a $1,000 investment in GMAB is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| GMAB Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $3.91 |
| End Date | Dec-01-2023 |
| End Price | $31.97 |
| # Prices | 121 |
| Min Date | Apr-30-2014 |
| Min Price | $3.70 |
| Max Date | Aug-31-2021 |
| Max Price | $47.39 |
| Total Return | 716.81% |
| Annualized Return | 23.16% |
| Current Value of $1,000 Purchase | $8,168 |
| Number Returns | 7,260 |
| Average Return | 164.20% |
| Number Profitable Returns | 6,297 |
| Percent Profitable Returns | 86.74% |
| Number Unprofitable Returns | 963 |
| Percent Unprofitable Returns | 13.26% |
| Profitable to Unprofitable Returns Ratio | 6.54 |
| GMAB Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $20,881,332,000 | Price to Sales | 1.23 |
| Earnings per Share | $0.9500 |
| PE Ratio | 33.65 |
| PE to Growth Ratio | 1.316 |
| Price to Book | 4.56 |
| PRICE DATA | |
| 52 Week High | $47.12 |
| 52 Week Low | $27.74 |
| Analyst Target Price | $41.96 |
| 50-Day Moving Average | $31.88 |
| 200-Day Moving Average | $36.98 |
| FINANCIAL DATA | |
| Revenue per Share | $26.07 |
| Revenue | $17,023,000,000 |
| Profit Margin | 25.2% |
| Return on Equity | 0.149% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
GMAB Compare Returns with S&P 500
GMAB Trendline Chart